BiotechTube
Home/Rejuvenation Technologies/Bob Fishman
BF

Bob Fishman

Director of Clinical Development

Rejuvenation Technologies

Therapeutic Areas

Pulmonary FibrosisChronic Liver DiseaseHematologic DiseasesAging

Rejuvenation Technologies Pipeline

DrugIndicationPhase
TeloAT2Pulmonary FibrosisPhase 1
TeloHepChronic Liver DiseasePhase 1
TeloHSCHematologic IndicationPhase 1

Leadership Team at Rejuvenation Technologies

JR
John Ramunas
Founder & CEO
GM
Glenn Markov
Founder & COO
DC
Daniel Chambers
Chief Medical Officer (Part-time)
View full Rejuvenation Technologies profile